By Debdeep Gupta | 03 Aug, 2026
Zydus Lifesciences shares in focus on EIR from USFDA; board meet on Aug 11
Zydus Lifesciences share price will remain in focus on August 3 following the company received Establishment Inspection Report (EIR) for its Ahmedabad facility.The company said it has received an EIR from the US Food and Drug Administration (USFDA) for its injectable manufacturing facility at Zydus Biotech Park, Ahmedabad, with a Voluntary Action Indicated (VAI) classification.The facility underwe...


